Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis
Recruiting now · Not applicable
Conditions studied: Telerehabilitation, Multiple Sclerosis, Cognitive Disorders, Neurorehabilitation
In brief
Non-Inferiority Study, Post-Market Clinical Investigation with a Device, Single-Blind Randomized Controlled Trial in a Cohort of Patients Diagnosed with Multiple Sclerosis (MS). The aim of the study is to assess whether a computer-based cognitive treatment delivered via telerehabilitation produces effects from T0 to T1 that are not inferior to those of an in-person treatment on sustained attention in a cohort of patients with MS. The secondary objective is to evaluate the effects of telerehabilitation compared to the same treatment delivered in person on attentional shifting, memory, executive functions, and daily functioning (including cognitive fatigue, quality of life, and mood) in patients with MS.
Key facts
- Study ID
- NCT06964581
- Run by
- Universita di Verona
- People needed
- 60
- Starts
- 2023-02-08
- Expected to finish
- 2025-09-30
- Last updated by the study team
- 2025-05-09
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of relapsing-remitting multiple sclerosis (RRMS), or primary progressive (PPMS) or secondary progressive (SPMS), defined by at least 3-6 months.
- Age between 18 and 65 years.
- Expanded Disability Status Scale (EDSS) between 3 and 5 to include patients with overall neurological disability from mild to moderate.
- Presence of one or more of the following cognitive disorders (reported by the patient and subsequently confirmed through the Oxford Cognitive Screen-OCS):
- Memory disorders
- Attention disorders
- Executive function disorders
- Availability of internet at the patient's home necessary for the tele-rehabilitation procedures.
- Adequate visual and auditory abilities to use the rehabilitation device.
You may not qualify if…
- Presence of other neurological conditions;
- Psychiatric disorders in medical history;
- Alcohol and/or drug abuse;
- Presence of uncorrected severe visual deficits.
Where it is running
- Azienda Ospedaliera Universitaria Integrata Verona - UOC di Neuroriabilitazione — Verona, verona, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.